BIO Asia International Conference

March 9-10, 2021・Grand Hyatt Tokyo, Japan

Partnering Companies

Below is a representative list of partnering companies for the 2020 Asia International Conference:

A*START: ETC/D3

A. Menarini Asia-Pacific Holdings

AbbVie

AbClon

Accurna

Aceras Life Sciences

Adare Pharmaceuticals

Aeterna Zentaris Gmbh

Affilogic

Ajinomoto Co.

AlphaCent GmbH

AMAG Pharmaceuticals

Amgen

Amgen Business Development

Amgen Strategy Commercialization & Innovation

Anima Biotech

Anthos Therapeutics

Apellis Pharmaceuticals

API Co.

Arbor Pharmaceuticals

Asahi Kasei Pharma Corporation

Asset Management Ventures

Astellas Pharma

Astellas Venture Management

Aurinia Pharmaceuticals

Aurora Partners K.K.

Ayala Pharma

BBC World Turkish

Berlin Partner for Business and Technology

BioCentury BioInnovation Capital

BioInvent International AB

BioLite, Inc.

Bionoxx

Biorchestra

Biotome

Boston Pharmaceuticals

Caladrius Biosciences

CDIB Capital Healthcare Ventures

CellSeed

Champions Oncology

Chaperone Investment

Chia Tai Tianqing Pharmaceutical Group Co.

Chiome Bioscience

Copenhagen Capacity

Covance Japan Co.

CureBio Co.

Daewoong pharmaceuticals Co.

Daiichi Sankyo Co.

Delta-Fly Pharma

Diurnal

Dot World Co.

Dr. Reddy's Laboratories

Dr. Wild & Co.

DrugCendR Hong Kong

Eddingpharm

Eight Roads Ventures Japan

Eisai Co.

Eli Lilly and Company

Elixiron Immunotherapeutics

Eloxx Pharmaceuticals

Engine Biosciences

Engrail Therapeutics

Entera Health

Ethypharm

Evaluate Japan

Experimental Drug Development Centre, Singapore

First Republic Bank

Garvan Insitute of Medical Research

GC Pharma

Gemseki

Genopole

Genovior Biotech Corporation

GI Innovation

GIP Genopole

GNT Pharma

Golden Biotechnology

Golden Helix

Great Bay Bio Limited

Hannol Ventures

Hanyang University

Harbin Pharma

Heartseed

Hotung International Company

IH BIO

Ildong Pharmaceutical

Illingworth Research Group

Immunic AG

Innovation Network Corporation of Japan

IQVIA Services  Japan K.K.

Italfarmaco

Itochu

JAFCO

JOGO Health

JSR Life Sciences

Kaken Pharmaceutical

Kine Sciences

Kissei Pharmaceutical

Kleiner, Perkins, Caufield & Byers

LG Chem

Liberi Group

Liminal BioSciences

Lineage Cell Therapeutics

M Bio Technology

Mammoth Biosciences

Merck

Middlemore Clinical Trials

Mission BioCapital

Mitsubishi UFJ Capital

Mitsui Global Investment

Momentum Biotech

Momotaro-Gene

Monocl AB

MSD K.K.

MSQ Ventures

NeuroVis

Newron Pharmaceuticals

Nimble

Nippon Boehringer Ingelheim Co.

Nissan Chemical Corporation

Nordic Bioscience Clinical Development

Novelty Nobility

Novotech CRO

ONC

OSE Immunotherapeutics

Otsuka Pharmacautical Co.

Perception Neuroscience

pH pharma Co.

PharmaResearch Products

Pharmstandard Ventures

Phenex Pharmaceuticals AG

Pierre Fabre

Premir Partners

Protalix

ProxyKine

Quark Biosciences

Questel Japan Co.

Rakuten Medical Japan

Remiges Ventures

Rockwell Medical

RubrYc Therapeutics

S&P Global Market Intelligence

Sage Therapeutics

Samsung Biologics

Sanofi

Sant-Yalla

Sanwa Kagaku Kenkyusho Co.

Servier

Shaperon

Shinsei Capital Partners

SmartAnalyst India

Socium

STADA Pharmaceuticals

Stelexis Therapeutics

Tad International

TAGCyx Biotechnologies

Takeda Pharmaceutical

Teijin Pharma Limited

Teon Therapeutics

ThinkCyte

Tian Shing Trading Co.

Toray Industries

Transcure Bioservices

Trinity Innovation Investment Management

twoXAR

Univercells

University of Texas, MD Anderson Cancer Center

VelocityHealth Securities

Verastem Oncology

Virometix AG

W Global Capital Limited

Whan In Pharm Co.

Y-Biologics

Zentiva

Zeria Pharmaceutical

Zoetis

 

 

Partnering Investors

 

Aceras Life Sciences

Asset Management Ventures

BioInnovation Capital

Chaperone Investment

Eight Roads Ventures Japan

First Republic Bank

Hannol Ventures

Harbin Pharma

JAFCO

Mitsubishi UFJ Capital

Mitsui Global Investment

Momentum Biotech

MSQ Ventures

Otsuka Pharmacautical Co.

Premir Partners

Shinsei Capital Partners

W Global Capital

 

 

*As of 2/14/2020